AU2003266243A1 - 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors - Google Patents
1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitorsInfo
- Publication number
- AU2003266243A1 AU2003266243A1 AU2003266243A AU2003266243A AU2003266243A1 AU 2003266243 A1 AU2003266243 A1 AU 2003266243A1 AU 2003266243 A AU2003266243 A AU 2003266243A AU 2003266243 A AU2003266243 A AU 2003266243A AU 2003266243 A1 AU2003266243 A1 AU 2003266243A1
- Authority
- AU
- Australia
- Prior art keywords
- pyrrolidine
- hepatitis
- cyano
- carbonyl
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0216985A GB0216985D0 (en) | 2002-07-22 | 2002-07-22 | Compounds |
GB0216985.2 | 2002-07-22 | ||
PCT/EP2003/008138 WO2004009543A2 (en) | 2002-07-22 | 2003-07-18 | 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003266243A1 true AU2003266243A1 (en) | 2004-02-09 |
AU2003266243A8 AU2003266243A8 (en) | 2004-02-09 |
Family
ID=9940904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003266243A Abandoned AU2003266243A1 (en) | 2002-07-22 | 2003-07-18 | 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003266243A1 (en) |
GB (1) | GB0216985D0 (en) |
WO (1) | WO2004009543A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0304494D0 (en) * | 2003-02-27 | 2003-04-02 | Glaxo Group Ltd | Compounds |
JP4663733B2 (en) * | 2004-10-29 | 2011-04-06 | シェーリング コーポレイション | Substituted 5-oxopyrazoles and substituted [1,2,4] triazoles as antiviral substances |
ES2381410T3 (en) | 2007-05-04 | 2012-05-28 | Vertex Pharmceuticals Incorporated | Combination therapy for the treatment of HCV infections |
WO2012031763A1 (en) * | 2010-09-08 | 2012-03-15 | Twincore Zentrum Fuer Experimentelle Und Klinische Infektionsforschung Gmbh | Use of inhibitors of phospholipase a2 for the treatment or prevention of flavivirus infection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001085720A1 (en) * | 2000-05-05 | 2001-11-15 | Smithkline Beecham Corporation | Novel anti-infectives |
EP1440070A1 (en) * | 2001-11-02 | 2004-07-28 | Glaxo Group Limited | 4-(5-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
US20050009873A1 (en) * | 2001-11-02 | 2005-01-13 | Gianpaolo Bravi | Acyl dihydro pyrrole derivatives as hcv inhibitors |
-
2002
- 2002-07-22 GB GB0216985A patent/GB0216985D0/en not_active Ceased
-
2003
- 2003-07-18 AU AU2003266243A patent/AU2003266243A1/en not_active Abandoned
- 2003-07-18 WO PCT/EP2003/008138 patent/WO2004009543A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB0216985D0 (en) | 2002-08-28 |
WO2004009543A3 (en) | 2004-03-18 |
WO2004009543A8 (en) | 2004-06-10 |
AU2003266243A8 (en) | 2004-02-09 |
WO2004009543A2 (en) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1070287A1 (en) | Hepatitis c virus inhibitors | |
IL182583A0 (en) | 4-methoxymethyl-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors | |
AU2003259155A1 (en) | Pharmaceutical compositions comprising hepatitis c viral protease inhibitors | |
EP1684787A4 (en) | Hepatitis c virus inhibitors | |
EP1684745A4 (en) | Hepatitis c virus inhibitors | |
AU2003261434A1 (en) | Iminothiazolidinones as inhibitors of hcv replication | |
AU2003293356A1 (en) | Dihydropyridinone derivatives as hne inhibitors | |
AU2003296586A1 (en) | Pyridazinone derivatives as cdk2-inhibitors | |
HK1078870A1 (en) | Heterocyclic tripeptides as hepatitis c inhibitors | |
AU2003255376A1 (en) | Piperidine-derivatives as pde4 inhibitors | |
AU2003224836A1 (en) | Dual-labeled nucleotides | |
AU2003260425A1 (en) | Dihydropyridine derivatives for use as human neutrophil elastase inhibitors | |
AU2003218758A1 (en) | Derivatives of 1-phenyl-3-phenylpyrazole as herbicides | |
AU2003258045A1 (en) | Novel gamma-lactams as beta-secretase inhibitors | |
PL377511A1 (en) | Mandelic acid derivatives | |
AU2003250482A1 (en) | Phthalimide derivatives as matrix metalloproteinase inhibitors | |
AU2003205558A1 (en) | Thioibotenic acid and derivatives thereof | |
AU2003294757A1 (en) | Formulations useful against hepatitis c virus infections | |
AU2003229474A1 (en) | Methods and compositions for detecting sars virus | |
AU2003215635A1 (en) | Thiazol-2-yl-imine compounds as pde-7 inhibitors | |
AU2003205817A1 (en) | Methods of nucleic acid amplification | |
AU2003266243A1 (en) | 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors | |
AU2003263517A1 (en) | Cyclic nitromethyl acetic acid derivatives | |
AU2003249491A1 (en) | Hyaluronic acid derivatives | |
AU2003229459A1 (en) | Methods of using thiazolidinedithione derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |